1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow COP protocol 2: new trials by email Literature Review of COP protocol 2 trials Research Report on COP protocol 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zanubrutinib Combined With G-CVP in Previously Untreated FL zanubrutinib, obinutuzumab,combined with CVP - Follicular Lymphoma ( FL) | Phase 2 | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 40 | 2025-01-01 | 2025-05-07 |
| Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma. cycolophosphamide, vacristine, and pednisone (CVP) x6 cycles followed by tositumomab and iodine I 131 tositumomab. - Lymphoma, Non-Hodgkin | Phase 2 | Completed | GlaxoSmithKline | 30 | 2000-02-01 | 2017-01-11 |
Lymphoma, Follicular (1) · Lymphoma, Non-Hodgkin (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · GlaxoSmithKline (1)
China (1)